CLABSI - Central Line Associated Bloodstream Infection
10
3
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
75.0%
-11.5% vs benchmark
10%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Efficacy & Cost Effectiveness of Antimicrobial-impregnated CVCs in CLABSI Prevention in a Malaysia Adult ICU
Duke Virtual IntEgrated Workflow
Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China
Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
Umbilical Venous Versus Peripherally Inserted Central Catheters in Neonates: A Prospective Cohort Study of Complications, Catheter Survival, and CLABSI"
Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps
Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition
Tunneled Peripherally Inserted Central Catheter (PICC) in Adult Patients and Associated Outcomes
Erythema at Exit Site & Tablet Camera
The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants